Journal of Renal Nutrition
Volume 14, Issue 3 , Pages 164-169 , July 2004

Zinc levels after iron supplementation in patients with chronic kidney disease

  • Denise Mafra, PhD

      Affiliations

    • Department of Nutrition, Federal University Fluminense, Niterói, Brazil
    • Corresponding Author InformationAddress reprint requests to Denise Mafra, PhD, R. Tavares de Macedo, 197/ 602, Icaraı́ Niterói—RJ, 24220 215, Brazil
    • ,
  • Lilian Cuppari, PhD

      Affiliations

    • Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
    • ,
  • Déborah I.T Fávaro, PhD

      Affiliations

    • Neutron Activation Analysis Laboratory—IPEN/CNEN, São Paulo, Brazil
    • ,
  • Sı́lvia M.F Cozzolino, PhD

      Affiliations

    • Laboratory of Minerals, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

References 

  1. Cousins RJ. Zinc. In:  Ziegler EE,  Filer LJ editor. Present Knowledge in Nutrition. Washington: ILSI Press; 1986;p. 293–306
  2. Blendis LM, Ampil M, Wilson DR, et al.  The importance of diet in the zinc deficiency of uremia. Am J Clin Nutr. 1981;34:2658–2661
  3. Zima T, Tesar V, Mestek O, et al.  Trace elements in end-stage renal disease. Blood Purif. 1999;17:187–198
  4. Mafra D, Cuppari L, Cozzolino SMF. Iron and zinc status of patients with chronic kidney disease who are not on dialysis. J Ren Nutr. 2002;12:38–41
  5. Silverberg DS, Blum M, Agbaria Z, et al.  An Intravenous iron for the treatment of predialysis patients. Kidney Int. 1999;55(suppl 69):79–85
  6. Silverberg DS, Blum M, Agbaria Z, et al.  The effect of I.V. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic kidney disease in the predialysis period. Clin Nephrol. 2001;55:212–219
  7. Hastka J, Lasserre JJ, Schwarzbec A, et al.  Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem. 1994;40:768–773
  8. Sunder-Plassmann G, Hörl WH. Erythropoietin and iron. Clin Nephrol. 1997;47:141–157
  9. Garrett S, Worwood M. Zinc protoporphyrin and iron-deficient erythropoiesis. Acta Haematol. 1994;91:21–25
  10. Fishbane S, Lynn RI. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients. Am J Kidney Dis. 1995;25:426–432
  11. Braun J, Hammerschmidt M, Schreiber M, et al.  Is zinc protophorphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?. Nephrol Dial Transplant. 1996;11:492–497
  12. Keys A, Fidanza F, Kcarvonen MJ. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329–343
  13. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake in patients with chronic renal failure. Kidney Int. 1985;27:58–65
  14. Gibson RS. Principles of Nutritional Assessment. New York: Oxford University Press; 1990;
  15. Pedersen NS, Morling N. Iron stores in blood donors evaluated by serum ferritin. Scand J Haematol. 1978;20:70–76
  16. In: National Kidney Foundation-DOQI Clinical practice guidelines for the treatment of anemia of chronic kidney disease. New York: National Kidney Foundation; 1997;p. 34–35
  17. Forster HV, Dempsey JA, Thomson J, et al.  Estimation of arterial pO2, pCO2, pH and lactate from arterialised blood. J Appl Physiol. 1972;32:134–137
  18. Association Official Analytical Chemists . Official Methods of Analysis of the AOAC. (15th ed). Washington: Association Official Analytical Chemists; 1990;
  19. Fávaro DIT, Hui MLT, Cozzolino SMF, et al.  Determination of some nutrients and toxic elements in different Brazilian regional diets by neutron activation analysis. J Trace Elements Med Biol. 1997;11:129–136
  20. Valderrábano F. Quality of life benefits of early anaemia treatment. Nephrol Dial Transplant. 2000;15:23–28
  21. Eckardt KU. Pathophysiology of renal anemia. Clin Nephrol. 2000;53:2–8
  22. Food and Nutrition Board . Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy of Sciences; 2001;
  23. Alam SM, Gupta A, Kumar S, et al.  The role of zinc in renal disease. J Indian Med Assoc. 1988;84:233–236
  24. Richard MJ, Arnaud J, Jurkovitz C, et al.  Trace elements and lipid peroxidation abnormalities in patients with chronic kidney disease. Nephron. 1991;57:10–15
  25. Hasanoglu E, Altan N, Sindel S, et al.  The Relationship between erythrocyte superoxide dismutase activity and plasma levels of some trace elements (Al, Cu, Zn) of dialysis patients. Gen Pharmacol. 1994;25:107–110
  26. Paniagua R. Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients. Nephron. 1996;60:147–150
  27. Lin TH, Chen JG, Liaw JM, et al.  Trace elements and lipid peroxidation on uremic patients on hemodialysis. Biol Trace Elem Res. 1996;51:277–283
  28. Canavese C, Grill A, Decostanzi E, et al.  Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients. Clin Nephrol. 2000;253:42–47
  29. Squarzoni G, Bariani L, Ughi M, et al.  Anidrasi carbonica aritrocitaria in soggetti sottoposti ad emodialisi periodica. Eur Rev Med Pharmacol Sci. 1990;12:253–258
  30. Mafra D, Cozzolino SMF. Erythrocyte zinc and carbonic anhydrase levels in nondialyzed chronic kidney disease patients. Clin Biochem. 2004;37:67–71
  31. Mimic-Oka J, Simic T, Ekmescic V, et al.  Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin Nephrol. 1995;44:44–48
  32. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif. 1998;16:290–300

☆ Supported by FAPESP.

PII: S1051-2276(04)00066-4

doi: 10.1053/j.jrn.2004.04.006

Journal of Renal Nutrition
Volume 14, Issue 3 , Pages 164-169 , July 2004

Article Tools

* Image Usage & Resolution